{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:45:59Z","timestamp":1793011559619,"version":"4.5.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11910-021-01130-1","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T14:02:55Z","timestamp":1624888975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":173,"title":["The Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection"],"prefix":"10.1007","volume":"21","author":[{"given":"Narges","family":"Moghimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Di Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Biller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Siegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Shekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise D.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Harkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Alaouieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelsomina","family":"Mansueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin A.","family":"Divani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"issue":"1","key":"1130_CR1","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1080\/22221751.2020.1825914","volume":"9","author":"TYM Leung","year":"2020","unstructured":"Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9(1):2190\u20139. https:\/\/doi.org\/10.1080\/22221751.2020.1825914.","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"1130_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z.","journal-title":"Nat Med"},{"issue":"11","key":"1130_CR3","doi-asserted-by":"publisher","first-page":"153195","DOI":"10.1016\/j.prp.2020.153195","volume":"216","author":"G Mansueto","year":"2020","unstructured":"Mansueto G. COVID-19: brief check through the pathologist\u2019s eye (autopsy archive). Pathol Res Pract. 2020;216(11):153195. https:\/\/doi.org\/10.1016\/j.prp.2020.153195.","journal-title":"Pathol Res Pract"},{"key":"1130_CR4","doi-asserted-by":"publisher","unstructured":"Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216,086.","DOI":"10.1136\/thoraxjnl-2020-216,086"},{"issue":"2","key":"1130_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jmv.26368","volume":"93","author":"SJ Halpin","year":"2021","unstructured":"Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013\u201322. https:\/\/doi.org\/10.1002\/jmv.26368A prospective study from the UK reporting on post-COVID discharge symptoms. The study recommended rehabilitation protocols to manage post-COVID symptoms and improve functional recovery.","journal-title":"J Med Virol"},{"issue":"3","key":"1130_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jinf.2021.01.004","volume":"82","author":"O Moreno-Per\u00e9z","year":"2021","unstructured":"Moreno-Per\u00e9z O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J Inf Secur. 2021;82(3):378\u201383. https:\/\/doi.org\/10.1016\/j.jinf.2021.01.004.","journal-title":"J Inf Secur"},{"issue":"8","key":"1130_CR7","doi-asserted-by":"publisher","first-page":"104941","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104941","volume":"29","author":"AA Divani","year":"2020","unstructured":"Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J, et al. Coronavirus disease 2019 and stroke: clinical manifestations and pathophysiological insights. J Stroke Cerebrovasc Dis. 2020;29(8):104941. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2020.104941.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"1130_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11910-021-01102-5","volume":"21","author":"S Andalib","year":"2021","unstructured":"Andalib S, Biller J, Di Napoli M, Moghimi N, McCullough LD, Rubinos CA, et al. Peripheral nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2021;21(3):9. https:\/\/doi.org\/10.1007\/s11910-021-01102-5.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"1130_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s11910-020-01079-7","volume":"20","author":"AA Divani","year":"2020","unstructured":"Divani AA, Andalib S, Biller J, Di Napoli M, Moghimi N, Rubinos CA, et al. Central nervous system manifestations associated with COVID-19. Curr Neurol Neurosci Rep. 2020;20(12):60. https:\/\/doi.org\/10.1007\/s11910-020-01079-7.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1130_CR10","doi-asserted-by":"publisher","unstructured":"YMJ G, Van Herck M, Delbressine JM, Vaes AW, Meys R, FVC M, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4). https:\/\/doi.org\/10.1183\/23120541.00542-2020In previously hospitalized and non-hospitalized patients with confirmed or suspected COVID-19, multiple symptoms were present about 3 months after symptoms onset.","DOI":"10.1183\/23120541.00542-2020"},{"issue":"30","key":"1130_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","volume":"69","author":"MW Tenforde","year":"2020","unstructured":"Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. 2020;69(30):993\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm6930e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1130_CR12","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","volume":"19","author":"B Hu","year":"2021","unstructured":"Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19(3):141\u201354. https:\/\/doi.org\/10.1038\/s41579-020-00459-7.","journal-title":"Nat Rev Microbiol"},{"key":"1130_CR13","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jama.2020.17709","volume":"324","author":"R Rubin","year":"2020","unstructured":"Rubin R. As their numbers grow, COVID-19 \u201clong haulers\u201d stump experts. JAMA. 2020;324:1381\u20133. https:\/\/doi.org\/10.1001\/jama.2020.17709.","journal-title":"JAMA."},{"issue":"6","key":"1130_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carfi","year":"2020","unstructured":"Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603\u20135. https:\/\/doi.org\/10.1001\/jama.2020.12603A prospective study assessing persistent symptoms in patients who were discharged from the hospital after recovery from COVID-19.","journal-title":"JAMA."},{"key":"1130_CR15","doi-asserted-by":"publisher","unstructured":"Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS et al. \u2018Long-COVID\u2019: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215818.","DOI":"10.1136\/thoraxjnl-2020-215818"},{"key":"1130_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1513\/AnnalsATS.202009-1175OC","volume":"18","author":"L Townsend","year":"2021","unstructured":"Townsend L, Dowds J, O\u2019Brien K, Sheill G, Dyer AH, O\u2019Kelly B, et al. Persistent poor health post-COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18:997\u20131003. https:\/\/doi.org\/10.1513\/AnnalsATS.202009-1175OC.","journal-title":"Ann Am Thorac Soc"},{"key":"1130_CR17","doi-asserted-by":"crossref","unstructured":"Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re\u2019em Y et al. Characterizing long covid in an international cohort: 7 months of symptoms and their impact. medRxiv. 2020:2020.12.24.20248802. doi:10.1101\/2020.12.24.20248802.","DOI":"10.2139\/ssrn.3820561"},{"key":"1130_CR18","doi-asserted-by":"publisher","unstructured":"Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(20)32656-8At 6 months after acute infection, COVID-19 survivors mainly suffered from fatigue or muscle weakness, sleep difficulties, and anxiety or depression. Patients who were more severely ill during their hospital stay had more severe impaired pulmonary diffusion capacities and abnormal chest imaging manifestations and were the main target population for the long-term recovery intervention.","DOI":"10.1016\/S0140-6736(20)32656-8"},{"issue":"4","key":"1130_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.7326\/M20-5661","volume":"174","author":"V Chopra","year":"2021","unstructured":"Chopra V, Flanders SA, O\u2019Malley M, Malani AN, Prescott HC. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576\u20138. https:\/\/doi.org\/10.7326\/M20-5661.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1130_CR20","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cmi.2020.09.052","volume":"27","author":"C Carvalho-Schneider","year":"2021","unstructured":"Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. 2021;27(2):258\u201363. https:\/\/doi.org\/10.1016\/j.cmi.2020.09.052.","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"1130_CR21","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.jinf.2020.08.029","volume":"81","author":"E Garrigues","year":"2020","unstructured":"Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Inf Secur. 2020;81(6):e4\u20136. https:\/\/doi.org\/10.1016\/j.jinf.2020.08.029.","journal-title":"J Inf Secur"},{"key":"1130_CR22","doi-asserted-by":"publisher","first-page":"110469","DOI":"10.1016\/j.mehy.2020.110469","volume":"146","author":"P Wostyn","year":"2021","unstructured":"Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469. https:\/\/doi.org\/10.1016\/j.mehy.2020.110469.","journal-title":"Med Hypotheses"},{"issue":"12","key":"1130_CR23","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","volume":"121","author":"K Fukuda","year":"1994","unstructured":"Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121(12):953\u20139. https:\/\/doi.org\/10.7326\/0003-4819-121-12-199412150-00009.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1130_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1472-6963-3-25","volume":"3","author":"WC Reeves","year":"2003","unstructured":"Reeves WC, Lloyd A, Vernon SD, Klimas N, Jason LA, Bleijenberg G, et al. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3(1):25. https:\/\/doi.org\/10.1186\/1472-6963-3-25.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1130_CR25","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","volume":"270","author":"BM Carruthers","year":"2011","unstructured":"Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270(4):327\u201338. https:\/\/doi.org\/10.1111\/j.1365-2796.2011.02428.x.","journal-title":"J Intern Med"},{"key":"1130_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3389\/fimmu.2018.00229","volume":"9","author":"J Blomberg","year":"2018","unstructured":"Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosen A. Infection elicited autoimmunity and myalgic encephalomyelitis\/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229. https:\/\/doi.org\/10.3389\/fimmu.2018.00229.","journal-title":"Front Immunol"},{"key":"1130_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1479-5876-10-191","volume":"10","author":"G Broderick","year":"2012","unstructured":"Broderick G, Katz BZ, Fernandes H, Fletcher MA, Klimas N, Smith FA, et al. Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue. J Transl Med. 2012;10:191. https:\/\/doi.org\/10.1186\/1479-5876-10-191.","journal-title":"J Transl Med"},{"key":"1130_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/B978-0-444-52901-5.00025-3","volume":"110","author":"R Moss-Morris","year":"2013","unstructured":"Moss-Morris R, Deary V, Castell B. Chronic fatigue syndrome. Handb Clin Neurol. 2013;110:303\u201314. https:\/\/doi.org\/10.1016\/B978-0-444-52901-5.00025-3.","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"1130_CR29","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mehy.2008.03.014","volume":"71","author":"B Grinde","year":"2008","unstructured":"Grinde B. Is chronic fatigue syndrome caused by a rare brain infection of a common, normally benign virus? Med Hypotheses. 2008;71(2):270\u20134. https:\/\/doi.org\/10.1016\/j.mehy.2008.03.014.","journal-title":"Med Hypotheses"},{"key":"1130_CR30","doi-asserted-by":"publisher","first-page":"e931447","DOI":"10.12659\/MSM.931447","volume":"27","author":"GB Stefano","year":"2021","unstructured":"Stefano GB. Historical Insight into Infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit. 2021;27:e931447. https:\/\/doi.org\/10.12659\/MSM.931447.","journal-title":"Med Sci Monit"},{"key":"1130_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1471-2377-11-37","volume":"11","author":"H Moldofsky","year":"2011","unstructured":"Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37. https:\/\/doi.org\/10.1186\/1471-2377-11-37.","journal-title":"BMC Neurol"},{"issue":"1","key":"1130_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-102-1-","volume":"102","author":"JF Jones","year":"1985","unstructured":"Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med. 1985;102(1):1\u20137. https:\/\/doi.org\/10.7326\/0003-4819-102-1-.","journal-title":"Ann Intern Med"},{"issue":"7568","key":"1130_CR33","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","volume":"333","author":"I Hickie","year":"2006","unstructured":"Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006;333(7568):575. https:\/\/doi.org\/10.1136\/bmj.38933.585764.AE.","journal-title":"BMJ."},{"issue":"Pt 4","key":"1130_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1099\/vir.0.017590-0","volume":"91","author":"JR Kerr","year":"2010","unstructured":"Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, et al. Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome\/myalgic encephalomyelitis. J Gen Virol. 2010;91(Pt 4):893\u20137. https:\/\/doi.org\/10.1099\/vir.0.017590-0.","journal-title":"J Gen Virol"},{"issue":"2","key":"1130_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1348\/174866407x218312","volume":"2","author":"JJ Sejvar","year":"2008","unstructured":"Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, et al. Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol. 2008;2(2):477\u201399. https:\/\/doi.org\/10.1348\/174866407x218312.","journal-title":"J Neuropsychol"},{"issue":"1","key":"1130_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jcp.2007.050054","volume":"61","author":"JK Chia","year":"2008","unstructured":"Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol. 2008;61(1):43\u20138. https:\/\/doi.org\/10.1136\/jcp.2007.050054.","journal-title":"J Clin Pathol"},{"issue":"5","key":"1130_CR37","doi-asserted-by":"publisher","first-page":"e0155884","DOI":"10.1371\/journal.pone.0155884","volume":"11","author":"G Morroy","year":"2016","unstructured":"Morroy G, Keijmel SP, Delsing CE, Bleijenberg G, Langendam M, Timen A, et al. Fatigue following acute Q-fever: a systematic literature review. PLoS One. 2016;11(5):e0155884. https:\/\/doi.org\/10.1371\/journal.pone.0155884.","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"1130_CR38","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/S1386-6532(06)70010-5","volume":"37","author":"AL Komaroff","year":"2006","unstructured":"Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006;37(Suppl 1):S39\u201346. https:\/\/doi.org\/10.1016\/S1386-6532(06)70010-5.","journal-title":"J Clin Virol"},{"issue":"1","key":"1130_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2006.10.011","volume":"38","author":"RC Seet","year":"2007","unstructured":"Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol. 2007;38(1):1\u20136. https:\/\/doi.org\/10.1016\/j.jcv.2006.10.011.","journal-title":"J Clin Virol"},{"issue":"25","key":"1130_CR40","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1056\/NEJMc1506576","volume":"373","author":"L Epstein","year":"2015","unstructured":"Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-ebola signs and symptoms in U.S. survivors. N Engl J Med. 2015;373(25):2484\u20136. https:\/\/doi.org\/10.1056\/NEJMc1506576.","journal-title":"N Engl J Med"},{"issue":"5","key":"1130_CR41","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1034\/j.1600-0463.2003.1110504.x","volume":"111","author":"GL Nicolson","year":"2003","unstructured":"Nicolson GL, Gan R, Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpes virus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. APMIS. 2003;111(5):557\u201366. https:\/\/doi.org\/10.1034\/j.1600-0463.2003.1110504.x.","journal-title":"APMIS."},{"issue":"6","key":"1130_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0002-9343(90)90520-n","volume":"88","author":"LH Sigal","year":"1990","unstructured":"Sigal LH. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med. 1990;88(6):577\u201381. https:\/\/doi.org\/10.1016\/0002-9343(90)90520-n.","journal-title":"Am J Med"},{"issue":"7","key":"1130_CR43","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cgh.2018.01.022","volume":"16","author":"S Litleskare","year":"2018","unstructured":"Litleskare S, Rortveit G, Eide GE, Hanevik K, Langeland N, Wensaas KA. Prevalence of irritable bowel syndrome and chronic fatigue 10 years after giardia infection. Clin Gastroenterol Hepatol. 2018;16(7):1064\u201372 e4. https:\/\/doi.org\/10.1016\/j.cgh.2018.01.022.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1130_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3389\/fped.2018.00412","volume":"6","author":"AR Valdez","year":"2018","unstructured":"Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. Estimating prevalence, demographics, and costs of ME\/CFS using large scale medical claims data and machine learning. Front Pediatr. 2018;6:412. https:\/\/doi.org\/10.3389\/fped.2018.00412.","journal-title":"Front Pediatr"},{"issue":"1","key":"1130_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","volume":"18","author":"EJ Lim","year":"2020","unstructured":"Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):100. https:\/\/doi.org\/10.1186\/s12967-020-02269-0.","journal-title":"J Transl Med"},{"key":"1130_CR46","doi-asserted-by":"publisher","unstructured":"Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, AS B, Gaini S, et al. Long COVID in the Faroe Islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa1792.","DOI":"10.1093\/cid\/ciaa1792"},{"issue":"22","key":"1130_CR47","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/archinternmed.2009.384","volume":"169","author":"MH Lam","year":"2009","unstructured":"Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. 2009;169(22):2142\u20137. https:\/\/doi.org\/10.1001\/archinternmed.2009.384.","journal-title":"Arch Intern Med"},{"issue":"46","key":"1130_CR48","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1016\/j.vaccine.2015.10.018","volume":"33","author":"P Magnus","year":"2015","unstructured":"Magnus P, Gunnes N, Tveito K, Bakken IJ, Ghaderi S, Stoltenberg C, et al. Chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME) is associated with pandemic influenza infection, but not with an adjuvanted pandemic influenza vaccine. Vaccine. 2015;33(46):6173\u20137. https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.018.","journal-title":"Vaccine."},{"issue":"12","key":"1130_CR49","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/archinte.167.12.1312","volume":"167","author":"CM Tansey","year":"2007","unstructured":"Tansey CM, Louie M, Loeb M, Gold WL, Muller MP, de Jager J, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167(12):1312\u201320. https:\/\/doi.org\/10.1001\/archinte.167.12.1312.","journal-title":"Arch Intern Med"},{"issue":"10224","key":"1130_CR50","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"R Lu","year":"2020","unstructured":"Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8.","journal-title":"Lancet."},{"key":"1130_CR51","doi-asserted-by":"publisher","unstructured":"Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis\/chronic fatigue syndrome. Diagnostics (Basel). 2019;9(3). https:\/\/doi.org\/10.3390\/diagnostics9030080.","DOI":"10.3390\/diagnostics9030080"},{"issue":"12","key":"1130_CR52","doi-asserted-by":"publisher","first-page":"841","DOI":"10.7326\/M15-0114","volume":"162","author":"ME Smith","year":"2015","unstructured":"Smith ME, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, et al. Treatment of myalgic encephalomyelitis\/chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(12):841\u201350. https:\/\/doi.org\/10.7326\/M15-0114.","journal-title":"Ann Intern Med"},{"key":"1130_CR53","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3389\/fneur.2020.00826","volume":"11","author":"L Nacul","year":"2020","unstructured":"Nacul L, O\u2019Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. How myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) progresses: the natural history of ME\/CFS. Front Neurol. 2020;11:826. https:\/\/doi.org\/10.3389\/fneur.2020.00826.","journal-title":"Front Neurol"},{"issue":"6","key":"1130_CR54","doi-asserted-by":"publisher","first-page":"102527","DOI":"10.1016\/j.autrev.2020.102527","volume":"19","author":"K Wirth","year":"2020","unstructured":"Wirth K, Scheibenbogen C. A Unifying hypothesis of the pathophysiology of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): recognitions from the finding of autoantibodies against ss2-adrenergic receptors. Autoimmun Rev. 2020;19(6):102527. https:\/\/doi.org\/10.1016\/j.autrev.2020.102527.","journal-title":"Autoimmun Rev"},{"issue":"24","key":"1130_CR55","doi-asserted-by":"publisher","first-page":"4017","DOI":"10.1021\/acschemneuro.0c00725","volume":"11","author":"AM Baig","year":"2020","unstructured":"Baig AM. Deleterious outcomes in Long-Hauler COVID-19: the effects of SARS-CoV-2 on the CNS in chronic COVID syndrome. ACS Chem Neurosci. 2020;11(24):4017\u201320. https:\/\/doi.org\/10.1021\/acschemneuro.0c00725.","journal-title":"ACS Chem Neurosci"},{"key":"1130_CR56","doi-asserted-by":"publisher","first-page":"m3026","DOI":"10.1136\/bmj.m3026","volume":"370","author":"T Greenhalgh","year":"2020","unstructured":"Greenhalgh T, Knight M, A\u2019Court C, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026. https:\/\/doi.org\/10.1136\/bmj.m3026.","journal-title":"BMJ."},{"issue":"5","key":"1130_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.clinthera.2019.02.011","volume":"41","author":"S Richman","year":"2019","unstructured":"Richman S, Morris MC, Broderick G, Craddock TJA, Klimas NG, Fletcher MA. Pharmaceutical Interventions in chronic fatigue syndrome: a literature-based commentary. Clin Ther. 2019;41(5):798\u2013805. https:\/\/doi.org\/10.1016\/j.clinthera.2019.02.011.","journal-title":"Clin Ther"},{"issue":"3","key":"1130_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s13317-013-0051-x","volume":"4","author":"EW Brenu","year":"2013","unstructured":"Brenu EW, Hardcastle SL, Atkinson GM, van Driel ML, Kreijkamp-Kaspers S, Ashton KJ, et al. Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights. 2013;4(3):69\u201380. https:\/\/doi.org\/10.1007\/s13317-013-0051-x.","journal-title":"Auto Immun Highlights"},{"issue":"1","key":"1130_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/cei.12043","volume":"172","author":"AS Bradley","year":"2013","unstructured":"Bradley AS, Ford B, Bansal AS. Altered functional B cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol. 2013;172(1):73\u201380. https:\/\/doi.org\/10.1111\/cei.12043.","journal-title":"Clin Exp Immunol"},{"key":"1130_CR60","doi-asserted-by":"publisher","first-page":"796","DOI":"10.3389\/fimmu.2019.00796","volume":"10","author":"JM Cliff","year":"2019","unstructured":"Cliff JM, King EC, Lee JS, Sepulveda N, Wolf AS, Kingdon C, et al. Cellular immune function in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Front Immunol. 2019;10:796. https:\/\/doi.org\/10.3389\/fimmu.2019.00796.","journal-title":"Front Immunol"},{"issue":"34","key":"1130_CR61","doi-asserted-by":"publisher","first-page":"E7150","DOI":"10.1073\/pnas.1710519114","volume":"114","author":"JG Montoya","year":"2017","unstructured":"Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U S A. 2017;114(34):E7150\u2013E8. https:\/\/doi.org\/10.1073\/pnas.1710519114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1130_CR62","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12967-017-1263-z","volume":"15","author":"C Scheibenbogen","year":"2017","unstructured":"Scheibenbogen C, Freitag H, Blanco J, Capelli E, Lacerda E, Authier J, et al. The European ME\/CFS Biomarker Landscape project: an initiative of the European network EUROMENE. J Transl Med. 2017;15(1):162. https:\/\/doi.org\/10.1186\/s12967-017-1263-z.","journal-title":"J Transl Med"},{"issue":"6","key":"1130_CR63","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s12035-018-1354-8","volume":"56","author":"OP Gunther","year":"2019","unstructured":"Gunther OP, Gardy JL, Stafford P, Fluge O, Mella O, Tang P, et al. Immunosignature analysis of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Mol Neurobiol. 2019;56(6):4249\u201357. https:\/\/doi.org\/10.1007\/s12035-018-1354-8.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"1130_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236148","volume":"15","author":"M Milivojevic","year":"2020","unstructured":"Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, et al. Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME\/CFS. PLoS One. 2020;15(7):e0236148. https:\/\/doi.org\/10.1371\/journal.pone.0236148.","journal-title":"PLoS One"},{"issue":"2","key":"1130_CR65","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/mp.2015.29","volume":"21","author":"M Hornig","year":"2016","unstructured":"Hornig M, Gottschalk G, Peterson DL, Knox KK, Schultz AF, Eddy ML, et al. Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis\/chronic fatigue syndrome. Mol Psychiatry. 2016;21(2):261\u20139. https:\/\/doi.org\/10.1038\/mp.2015.29.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"1130_CR66","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/qjmed\/hcn123","volume":"101","author":"A Hoad","year":"2008","unstructured":"Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. 2008;101(12):961\u20135. https:\/\/doi.org\/10.1093\/qjmed\/hcn123.","journal-title":"QJM."},{"issue":"2","key":"1130_CR67","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/joim.12564","volume":"281","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, et al. Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome. J Intern Med. 2017;281(2):179\u201388. https:\/\/doi.org\/10.1111\/joim.12564.","journal-title":"J Intern Med"},{"issue":"1","key":"1130_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12967-019-02196-9","volume":"18","author":"DY Kim","year":"2020","unstructured":"Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Systematic review of randomized controlled trials for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). J Transl Med. 2020;18(1):7. https:\/\/doi.org\/10.1186\/s12967-019-02196-9.","journal-title":"J Transl Med"},{"key":"1130_CR69","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41421-020-0168-9","volume":"6","author":"W Wen","year":"2020","unstructured":"Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6:31. https:\/\/doi.org\/10.1038\/s41421-020-0168-9.","journal-title":"Cell Discov"},{"issue":"4","key":"1130_CR70","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41590-021-00901-9","volume":"22","author":"M Buszko","year":"2021","unstructured":"Buszko M, Nita-Lazar A, Park JH, Schwartzberg PL, Verthelyi D, Young HA, et al. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 2021;22(4):404\u201311. https:\/\/doi.org\/10.1038\/s41590-021-00901-9.","journal-title":"Nat Immunol"},{"issue":"9","key":"1130_CR71","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno X, Gomez-Ambrosi J, Rodriguez A, Becerril S, Fruhbeck G, Catalan V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Investig. 2018;48(9):e12997. https:\/\/doi.org\/10.1111\/eci.12997.","journal-title":"Eur J Clin Investig"},{"issue":"8","key":"1130_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04696","volume":"6","author":"PHJ van der Voort","year":"2020","unstructured":"van der Voort PHJ, Moser J, Zandstra DF, Muller Kobold AC, Knoester M, Calkhoven CF, et al. Leptin levels in SARS-CoV-2 infection related respiratory failure: a cross-sectional study and a pathophysiological framework on the role of fat tissue. Heliyon. 2020;6(8):e04696. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e04696.","journal-title":"Heliyon."},{"key":"1130_CR73","doi-asserted-by":"publisher","unstructured":"Wang J, Xu Y, Zhang X, Wang S, Peng Z, Guo J, et al. Leptin correlates with monocytes activation and severe condition in COVID-19 patients. J Leukoc Biol. 2021. https:\/\/doi.org\/10.1002\/JLB.5HI1020-704R.","DOI":"10.1002\/JLB.5HI1020-704R"},{"issue":"8","key":"1130_CR74","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41366-020-0598-3","volume":"44","author":"AP Demidowich","year":"2020","unstructured":"Demidowich AP, Levine JA, Apps R, Cheung FK, Chen J, Fantoni G, et al. Colchicine\u2019s effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial. Int J Obes. 2020;44(8):1793\u20139. https:\/\/doi.org\/10.1038\/s41366-020-0598-3.","journal-title":"Int J Obes"},{"issue":"5","key":"1130_CR75","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1182\/bloodadvances.2020003568","volume":"5","author":"ML Meizlish","year":"2021","unstructured":"Meizlish ML, Pine AB, Bishai JD, Goshua G, Nadelmann ER, Simonov M, et al. A neutrophil activation signature predicts critical illness and mortality in COVID-19. Blood Adv. 2021;5(5):1164\u201377. https:\/\/doi.org\/10.1182\/bloodadvances.2020003568.","journal-title":"Blood Adv"},{"issue":"1","key":"1130_CR76","doi-asserted-by":"publisher","first-page":"C57","DOI":"10.1152\/ajpcell.00426.2020","volume":"320","author":"S Ajaz","year":"2021","unstructured":"Ajaz S, McPhail MJ, Singh KK, Mujib S, Trovato FM, Napoli S, et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19. Am J Phys Cell Phys. 2021;320(1):C57\u201365. https:\/\/doi.org\/10.1152\/ajpcell.00426.2020.","journal-title":"Am J Phys Cell Phys"},{"issue":"1","key":"1130_CR77","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-020-02356-2","volume":"18","author":"TK Huth","year":"2020","unstructured":"Huth TK, Eaton-Fitch N, Staines D, Marshall-Gradisnik S. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis\/Systemic Exertion Intolerance Disease (CFS\/ME\/SEID). J Transl Med. 2020;18(1):198. https:\/\/doi.org\/10.1186\/s12967-020-02356-2.","journal-title":"J Transl Med"},{"issue":"2","key":"1130_CR78","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molmet.2013.11.005","volume":"3","author":"BM Kenwood","year":"2014","unstructured":"Kenwood BM, Weaver JL, Bajwa A, Poon IK, Byrne FL, Murrow BA, et al. Identification of a novel mitochondrial uncoupler that does not depolarize the plasma membrane. Mol Metab. 2014;3(2):114\u201323. https:\/\/doi.org\/10.1016\/j.molmet.2013.11.005.","journal-title":"Mol Metab"},{"key":"1130_CR79","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395. https:\/\/doi.org\/10.1146\/annurev-immunol-073119-095439.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"1130_CR80","doi-asserted-by":"publisher","first-page":"e49799","DOI":"10.15252\/embr.201949799","volume":"21","author":"JS Riley","year":"2020","unstructured":"Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020;21(4):e49799. https:\/\/doi.org\/10.15252\/embr.201949799.","journal-title":"EMBO Rep"},{"key":"1130_CR81","doi-asserted-by":"publisher","unstructured":"Chen Y, Gu S, Chen Y, Lu H, Shi D, Guo J, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2021:gutjnl-2021-324090. https:\/\/doi.org\/10.1136\/gutjnl-2021-324090.","DOI":"10.1136\/gutjnl-2021-324090"},{"issue":"3","key":"1130_CR82","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1053\/j.gastro.2020.05.048","volume":"159","author":"T Zuo","year":"2020","unstructured":"Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944\u201355 e8. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.048.","journal-title":"Gastroenterology."},{"issue":"4","key":"1130_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s10286-020-00714-0","volume":"30","author":"DS Goldstein","year":"2020","unstructured":"Goldstein DS. The extended autonomic system, dyshomeostasis, and COVID-19. Clin Auton Res. 2020;30(4):299\u2013315. https:\/\/doi.org\/10.1007\/s10286-020-00714-0.","journal-title":"Clin Auton Res"},{"issue":"7","key":"1130_CR84","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1172\/JCI139642","volume":"130","author":"MF Konig","year":"2020","unstructured":"Konig MF, Powell M, Staedtke V, Bai RY, Thomas DL, Fischer N, et al. Preventing cytokine storm syndrome in COVID-19 using alpha-1 adrenergic receptor antagonists. J Clin Invest. 2020;130(7):3345\u20137. https:\/\/doi.org\/10.1172\/JCI139642.","journal-title":"J Clin Invest"},{"issue":"7735","key":"1130_CR85","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-018-0774-y","volume":"564","author":"V Staedtke","year":"2018","unstructured":"Staedtke V, Bai RY, Kim K, Darvas M, Davila ML, Riggins GJ, et al. Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome. Nature. 2018;564(7735):273\u20137. https:\/\/doi.org\/10.1038\/s41586-018-0774-y.","journal-title":"Nature."},{"issue":"5","key":"1130_CR86","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/14017431.2017.1355068","volume":"51","author":"M Ruzieh","year":"2017","unstructured":"Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J. 2017;51(5):243\u20137. https:\/\/doi.org\/10.1080\/14017431.2017.1355068.","journal-title":"Scand Cardiovasc J"},{"issue":"1","key":"1130_CR87","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","volume":"1","author":"H Chu","year":"2020","unstructured":"Chu H, Chan JF, Yuen TT, Shuai H, Yuan S, Wang Y, et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1(1):e14\u201323. https:\/\/doi.org\/10.1016\/S2666-5247(20)30004-5.","journal-title":"Lancet Microbe"},{"issue":"1","key":"1130_CR88","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.chom.2020.05.020","volume":"28","author":"SH Sun","year":"2020","unstructured":"Sun SH, Chen Q, Gu HJ, Yang G, Wang YX, Huang XY, et al. A mouse model of SARS-CoV-2 infection and pathogenesis. Cell Host Microbe. 2020;28(1):124\u201333 e4. https:\/\/doi.org\/10.1016\/j.chom.2020.05.020.","journal-title":"Cell Host Microbe"},{"issue":"10","key":"1130_CR89","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41422-020-0390-x","volume":"30","author":"BZ Zhang","year":"2020","unstructured":"Zhang BZ, Chu H, Han S, Shuai H, Deng J, Hu YF, et al. SARS-CoV-2 infects human neural progenitor cells and brain organoids. Cell Res. 2020;30(10):928\u201331. https:\/\/doi.org\/10.1038\/s41422-020-0390-x.","journal-title":"Cell Res"},{"issue":"2","key":"1130_CR90","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s12020-020-02325-1","volume":"68","author":"R Pal","year":"2020","unstructured":"Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications. Endocrine. 2020;68(2):251\u20132. https:\/\/doi.org\/10.1007\/s12020-020-02325-1.","journal-title":"Endocrine."},{"issue":"2","key":"1130_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1365-2265.2005.02325.x","volume":"63","author":"MK Leow","year":"2005","unstructured":"Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol. 2005;63(2):197\u2013202. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02325.x.","journal-title":"Clin Endocrinol"},{"issue":"7","key":"1130_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2215-0366(20)30203-0","volume":"7","author":"JP Rogers","year":"2020","unstructured":"Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611\u201327. https:\/\/doi.org\/10.1016\/S2215-0366(20)30203-0If SARS-CoV-2 infection follows a similar course to that with SARS or MERS, most patients should recover without experiencing mental illness. SARS-CoV-2 may cause delirium in a significant proportion of patients in the acute stage. Clinicians should be aware of the possibility of depression, anxiety, fatigue, post-traumatic stress disorder, and rarer neuropsychiatric syndromes in the chronic stage.","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"1130_CR93","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/s41582-020-0398-3","volume":"16","author":"A Pezzini","year":"2020","unstructured":"Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16(11):636\u201344. https:\/\/doi.org\/10.1038\/s41582-020-0398-3.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"1130_CR94","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00415-020-10067-3","volume":"268","author":"X Chen","year":"2021","unstructured":"Chen X, Laurent S, Onur OA, Kleineberg NN, Fink GR, Schweitzer F, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268(2):392\u2013402. https:\/\/doi.org\/10.1007\/s00415-020-10067-3.","journal-title":"J Neurol"},{"issue":"2","key":"1130_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/21641846.2020.1778227","volume":"8","author":"MF Islam","year":"2020","unstructured":"Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue: Biomedicine, Health & Behavior. 2020;8(2):61\u20139. https:\/\/doi.org\/10.1080\/21641846.2020.1778227.","journal-title":"Fatigue: Biomedicine, Health & Behavior"},{"issue":"4","key":"1130_CR96","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1021\/acschemneuro.0c00793","volume":"12","author":"SJ Yong","year":"2021","unstructured":"Yong SJ. persistent brainstem dysfunction in long-COVID: a hypothesis. ACS Chem Neurosci. 2021;12(4):573\u201380. https:\/\/doi.org\/10.1021\/acschemneuro.0c00793.","journal-title":"ACS Chem Neurosci"},{"key":"1130_CR97","doi-asserted-by":"publisher","first-page":"113267","DOI":"10.1016\/j.psychres.2020.113267","volume":"291","author":"LZ Li","year":"2020","unstructured":"Li LZ, Wang S. Prevalence and predictors of general psychiatric disorders and loneliness during COVID-19 in the United Kingdom. Psychiatry Res. 2020;291:113267. https:\/\/doi.org\/10.1016\/j.psychres.2020.113267.","journal-title":"Psychiatry Res"},{"key":"1130_CR98","doi-asserted-by":"publisher","first-page":"579038","DOI":"10.3389\/fpsyg.2020.579038","volume":"11","author":"M Orgiles","year":"2020","unstructured":"Orgiles M, Morales A, Delvecchio E, Mazzeschi C, Espada JP. Immediate psychological effects of the COVID-19 quarantine in youth from Italy and Spain. Front Psychol. 2020;11:579038. https:\/\/doi.org\/10.3389\/fpsyg.2020.579038.","journal-title":"Front Psychol"},{"key":"1130_CR99","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amsu.2020.07.054","volume":"57","author":"C Napoli","year":"2020","unstructured":"Napoli C, Tritto I, Benincasa G, Mansueto G, Ambrosio G. Cardiovascular involvement during COVID-19 and clinical implications in elderly patients. A review. Ann Med Surg (Lond). 2020;57:236\u201343. https:\/\/doi.org\/10.1016\/j.amsu.2020.07.054.","journal-title":"Ann Med Surg (Lond)"},{"key":"1130_CR100","doi-asserted-by":"publisher","first-page":"104174","DOI":"10.1016\/j.archger.2020.104174","volume":"90","author":"C Napoli","year":"2020","unstructured":"Napoli C, Tritto I, Mansueto G, Coscioni E, Ambrosio G. Immunosenescence exacerbates the COVID-19. Arch Gerontol Geriatr. 2020;90:104174. https:\/\/doi.org\/10.1016\/j.archger.2020.104174.","journal-title":"Arch Gerontol Geriatr"},{"issue":"3","key":"1130_CR101","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3976","volume":"3","author":"J Lai","year":"2020","unstructured":"Lai J, Ma S, Wang Y, Cai Z, Hu J, Wei N, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw Open. 2020;3(3):e203976. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.3976.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1130_CR102","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/ijgo.13249","volume":"150","author":"V Zanardo","year":"2020","unstructured":"Zanardo V, Manghina V, Giliberti L, Vettore M, Severino L, Straface G. Psychological impact of COVID-19 quarantine measures in northeastern Italy on mothers in the immediate postpartum period. Int J Gynaecol Obstet. 2020;150(2):184\u20138. https:\/\/doi.org\/10.1002\/ijgo.13249.","journal-title":"Int J Gynaecol Obstet"},{"issue":"3","key":"1130_CR103","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1021\/acschemneuro.8b00571","volume":"10","author":"M Dresler","year":"2019","unstructured":"Dresler M, Sandberg A, Bublitz C, Ohla K, Trenado C, Mroczko-Wasowicz A, et al. Hacking the brain: dimensions of cognitive enhancement. ACS Chem Neurosci. 2019;10(3):1137\u201348. https:\/\/doi.org\/10.1021\/acschemneuro.8b00571.","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"1130_CR104","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/pnp.698","volume":"25","author":"T Gaber","year":"2021","unstructured":"Gaber T. Assessment and management of post-COVID fatigue. Progress in Neurology and Psychiatry. 2021;25(1):36\u20139. https:\/\/doi.org\/10.1002\/pnp.698.","journal-title":"Progress in Neurology and Psychiatry"},{"issue":"1","key":"1130_CR105","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s13195-020-00744-w","volume":"12","author":"S Miners","year":"2020","unstructured":"Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther. 2020;12(1):170. https:\/\/doi.org\/10.1186\/s13195-020-00744-w.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"1130_CR106","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1474-4422(21)00059-4","volume":"20","author":"The Lancet N","year":"2021","unstructured":"The Lancet N. Long COVID: understanding the neurological effects. The Lancet Neurology. 2021;20(4):247. https:\/\/doi.org\/10.1016\/S1474-4422(21)00059-4.","journal-title":"The Lancet Neurology"},{"key":"1130_CR107","doi-asserted-by":"publisher","unstructured":"Beghi E, Helbok R, Crean M, Chou SH, McNett M, Moro E, et al. The European Academy of Neurology COVID-19 registry (ENERGY): an international instrument for surveillance of neurological complications in patients with COVID-19. Eur J Neurol. 2020. https:\/\/doi.org\/10.1111\/ene.14652.","DOI":"10.1111\/ene.14652"},{"issue":"10","key":"1130_CR108","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S1474-4422(20)30322-7","volume":"19","author":"R Helbok","year":"2020","unstructured":"Helbok R, Chou SH, Beghi E, Mainali S, Frontera J, Robertson C, et al. NeuroCOVID: it\u2019s time to join forces globally. Lancet Neurol. 2020;19(10):805\u20136. https:\/\/doi.org\/10.1016\/S1474-4422(20)30322-7.","journal-title":"Lancet Neurol"},{"key":"1130_CR109","doi-asserted-by":"publisher","first-page":"116884","DOI":"10.1016\/j.jns.2020.116884","volume":"414","author":"GC Roman","year":"2020","unstructured":"Roman GC, Spencer PS, Reis J, Buguet A, Faris MEA, Katrak SM, et al. The neurology of COVID-19 revisited: a proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries. J Neurol Sci. 2020;414:116884. https:\/\/doi.org\/10.1016\/j.jns.2020.116884.","journal-title":"J Neurol Sci"},{"key":"1130_CR110","doi-asserted-by":"publisher","unstructured":"Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. 2020;324(22):2251-2. doi:https:\/\/doi.org\/10.1001\/jama.2020.22717.","DOI":"10.1001\/jama.2020.22717"},{"issue":"1","key":"1130_CR111","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41467-020-20568-4","volume":"12","author":"JJA van Kampen","year":"2021","unstructured":"van Kampen JJA, van de Vijver D, Fraaij PLA, Haagmans BL, Lamers MM, Okba N, et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021;12(1):267. https:\/\/doi.org\/10.1038\/s41467-020-20568-4.","journal-title":"Nat Commun"},{"issue":"1","key":"1130_CR112","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1186\/s12889-017-4968-2","volume":"17","author":"E Stormorken","year":"2017","unstructured":"Stormorken E, Jason LA, Kirkevold M. Factors impacting the illness trajectory of post-infectious fatigue syndrome: a qualitative study of adults\u2019 experiences. BMC Public Health. 2017;17(1):952. https:\/\/doi.org\/10.1186\/s12889-017-4968-2.","journal-title":"BMC Public Health"},{"issue":"11","key":"1130_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240784","volume":"15","author":"L Townsend","year":"2020","unstructured":"Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784. https:\/\/doi.org\/10.1371\/journal.pone.0240784.","journal-title":"PLoS One"},{"key":"1130_CR114","doi-asserted-by":"publisher","first-page":"606824","DOI":"10.3389\/fmed.2020.606824","volume":"7","author":"AL Komaroff","year":"2020","unstructured":"Komaroff AL, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis\/chronic fatigue syndrome? Front Med (Lausanne). 2020;7:606824. https:\/\/doi.org\/10.3389\/fmed.2020.606824.","journal-title":"Front Med (Lausanne)"},{"issue":"8","key":"1130_CR115","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/gerona\/glq064","volume":"65","author":"E Moreh","year":"2010","unstructured":"Moreh E, Jacobs JM, Stessman J. Fatigue, function, and mortality in older adults. J Gerontol A Biol Sci Med Sci. 2010;65(8):887\u201395. https:\/\/doi.org\/10.1093\/gerona\/glq064.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"10","key":"1130_CR116","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576\u201390. https:\/\/doi.org\/10.1038\/s41574-018-0059-4.","journal-title":"Nat Rev Endocrinol"},{"issue":"10229","key":"1130_CR117","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet."},{"key":"1130_CR118","doi-asserted-by":"publisher","first-page":"m1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng KK. Covid-19: risk factors for severe disease and death. BMJ. 2020;368:m1198. https:\/\/doi.org\/10.1136\/bmj.m1198.","journal-title":"BMJ."},{"issue":"4","key":"1130_CR119","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/cid\/civ952","volume":"62","author":"JG Petrie","year":"2016","unstructured":"Petrie JG, Cheng C, Malosh RE, VanWormer JJ, Flannery B, Zimmerman RK, et al. Illness severity and work productivity loss among working adults with medically attended acute respiratory illnesses: US influenza vaccine effectiveness network 2012-2013. Clin Infect Dis. 2016;62(4):448\u201355. https:\/\/doi.org\/10.1093\/cid\/civ952.","journal-title":"Clin Infect Dis"},{"key":"1130_CR120","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fped.2019.00206","volume":"7","author":"M Perez","year":"2019","unstructured":"Perez M, Jaundoo R, Hilton K, Del Alamo A, Gemayel K, Klimas NG, et al. Genetic predisposition for immune system, hormone, and metabolic dysfunction in myalgic encephalomyelitis\/chronic fatigue syndrome: a pilot study. Front Pediatr. 2019;7:206. https:\/\/doi.org\/10.3389\/fped.2019.00206.","journal-title":"Front Pediatr"},{"issue":"8926","key":"1130_CR121","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/s0140-6736(94)92833-9","volume":"344","author":"H Cope","year":"1994","unstructured":"Cope H, David A, Pelosi A, Mann A. Predictors of chronic \u201cpostviral\u201d fatigue. Lancet. 1994;344(8926):864\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(94)92833-9.","journal-title":"Lancet."},{"issue":"1","key":"1130_CR122","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/21642850.2013.869176","volume":"2","author":"LA Jason","year":"2014","unstructured":"Jason LA, Katz BZ, Shiraishi Y, Mears CJ, Im Y, Taylor R. Predictors of post-infectious chronic fatigue syndrome in adolescents. Health Psychol Behav Med. 2014;2(1):41\u201351. https:\/\/doi.org\/10.1080\/21642850.2013.869176.","journal-title":"Health Psychol Behav Med"},{"key":"1130_CR123","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fnbeh.2018.00154","volume":"12","author":"K Kokubun","year":"2018","unstructured":"Kokubun K, Nemoto K, Oka H, Fukuda H, Yamakawa Y, Watanabe Y. Association of fatigue and stress with gray matter volume. Front Behav Neurosci. 2018;12:154. https:\/\/doi.org\/10.3389\/fnbeh.2018.00154.","journal-title":"Front Behav Neurosci"},{"key":"1130_CR124","doi-asserted-by":"publisher","unstructured":"Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020;56(1). https:\/\/doi.org\/10.1183\/13993003.01494-2020.","DOI":"10.1183\/13993003.01494-2020"},{"issue":"1","key":"1130_CR125","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13643-021-01620-w","volume":"10","author":"A Kalin","year":"2021","unstructured":"Kalin A, Javid B, Knight M, Inada-Kim M, Greenhalgh T. Direct and indirect evidence of efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: a rapid systematic review. Syst Rev. 2021;10(1):77. https:\/\/doi.org\/10.1186\/s13643-021-01620-w.","journal-title":"Syst Rev"},{"issue":"2","key":"1130_CR126","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1213\/ANE.0000000000004986","volume":"131","author":"S Mantha","year":"2020","unstructured":"Mantha S, Tripuraneni SL, Roizen MF, Fleisher LA. Proposed modifications in the 6-Minute Walk Test for potential application in patients with mild COVID-19: a step to optimize triage guidelines. Anesth Analg. 2020;131(2):398\u2013402. https:\/\/doi.org\/10.1213\/ANE.0000000000004986.","journal-title":"Anesth Analg"},{"key":"1130_CR127","doi-asserted-by":"publisher","first-page":"117271","DOI":"10.1016\/j.jns.2020.117271","volume":"420","author":"P Ortelli","year":"2021","unstructured":"Ortelli P, Ferrazzoli D, Sebastianelli L, Engl M, Romanello R, Nardone R, et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J Neurol Sci. 2021;420:117271. https:\/\/doi.org\/10.1016\/j.jns.2020.117271.","journal-title":"J Neurol Sci"},{"issue":"16","key":"1130_CR128","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1136\/bjsports-2020-102596","volume":"54","author":"RM Barker-Davies","year":"2020","unstructured":"Barker-Davies RM, O\u2019Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020;54(16):949\u201359. https:\/\/doi.org\/10.1136\/bjsports-2020-102596.","journal-title":"Br J Sports Med"},{"key":"1130_CR129","doi-asserted-by":"publisher","unstructured":"Friedman KJ, Murovska M, Pheby DFH, Zalewski P. Our Evolving Understanding of ME\/CFS. Medicina (Kaunas). 2021;57(3). https:\/\/doi.org\/10.3390\/medicina57030200.","DOI":"10.3390\/medicina57030200"},{"issue":"1","key":"1130_CR130","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-020-02455-0","volume":"18","author":"EJ Lim","year":"2020","unstructured":"Lim EJ, Son CG. Review of case definitions for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Transl Med. 2020;18(1):289. https:\/\/doi.org\/10.1186\/s12967-020-02455-0.","journal-title":"J Transl Med"},{"key":"1130_CR131","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1476-5918-7-6","volume":"7","author":"LA Jason","year":"2008","unstructured":"Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME\/CFS: individual and societal costs. Dyn Med. 2008;7:6. https:\/\/doi.org\/10.1186\/1476-5918-7-6.","journal-title":"Dyn Med"},{"key":"1130_CR132","doi-asserted-by":"publisher","first-page":"105465","DOI":"10.1016\/j.phrs.2021.105465","volume":"165","author":"PL Toogood","year":"2021","unstructured":"Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): where will the drugs come from? Pharmacol Res. 2021;165:105465. https:\/\/doi.org\/10.1016\/j.phrs.2021.105465.","journal-title":"Pharmacol Res"},{"issue":"9","key":"1130_CR133","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4088\/jcp.v61n0909","volume":"61","author":"IB Hickie","year":"2000","unstructured":"Hickie IB, Wilson AJ, Wright JM, Bennett BK, Wakefield D, Lloyd AR. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome. J Clin Psychiatry. 2000;61(9):643\u20138. https:\/\/doi.org\/10.4088\/jcp.v61n0909.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"1130_CR134","doi-asserted-by":"publisher","first-page":"167 e23","DOI":"10.1016\/j.amjmed.2005.07.047","volume":"119","author":"D Blockmans","year":"2006","unstructured":"Blockmans D, Persoons P, Van Houdenhove B, Bobbaers H. Does methylphenidate reduce the symptoms of chronic fatigue syndrome? Am J Med. 2006;119(2):167 e23\u201330. https:\/\/doi.org\/10.1016\/j.amjmed.2005.07.047.","journal-title":"Am J Med"},{"issue":"7","key":"1130_CR135","first-page":"11064","volume":"8","author":"JD Kaiser","year":"2015","unstructured":"Kaiser JD. A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome. Int J Clin Exp Med. 2015;8(7):11064\u201374.","journal-title":"Int J Clin Exp Med"},{"issue":"26","key":"1130_CR136","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1056\/NEJM198812293192602","volume":"319","author":"SE Straus","year":"1988","unstructured":"Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, et al. Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial. N Engl J Med. 1988;319(26):1692\u20138. https:\/\/doi.org\/10.1056\/NEJM198812293192602.","journal-title":"N Engl J Med"},{"issue":"6","key":"1130_CR137","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1586\/17512433.2016.1172960","volume":"9","author":"WM Mitchell","year":"2016","unstructured":"Mitchell WM. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME). Expert Rev Clin Pharmacol. 2016;9(6):755\u201370. https:\/\/doi.org\/10.1586\/17512433.2016.1172960.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"3","key":"1130_CR138","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031334","volume":"7","author":"DR Strayer","year":"2012","unstructured":"Strayer DR, Carter WA, Stouch BC, Stevens SR, Bateman L, Cimoch PJ, et al. A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7(3):e31334. https:\/\/doi.org\/10.1371\/journal.pone.0031334.","journal-title":"PLoS One"},{"issue":"8","key":"1130_CR139","doi-asserted-by":"publisher","first-page":"557","DOI":"10.7326\/m16-2391","volume":"166","author":"ME Roerink","year":"2017","unstructured":"Roerink ME, Bredie SJH, Heijnen M, Dinarello CA, Knoop H, Van der Meer JWM. Cytokine inhibition in patients with chronic fatigue syndrome: a randomized trial. Ann Intern Med. 2017;166(8):557\u201364. https:\/\/doi.org\/10.7326\/m16-2391.","journal-title":"Ann Intern Med"},{"issue":"7","key":"1130_CR140","doi-asserted-by":"publisher","first-page":"e0129898","DOI":"10.1371\/journal.pone.0129898","volume":"10","author":"\u00d8 Fluge","year":"2015","unstructured":"Fluge \u00d8, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, et al. B-lymphocyte depletion in myalgic encephalopathy\/chronic fatigue syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment. PLoS One. 2015;10(7):e0129898. https:\/\/doi.org\/10.1371\/journal.pone.0129898.","journal-title":"PLoS One"},{"key":"1130_CR141","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fmed.2020.00162","volume":"7","author":"IG Rekeland","year":"2020","unstructured":"Rekeland IG, Fossa A, Lande A, Ktoridou-Valen I, Sorland K, Holsen M, et al. Intravenous cyclophosphamide in myalgic encephalomyelitis\/chronic fatigue syndrome. An Open-Label Phase II Study. Front Med (Lausanne). 2020;7:162. https:\/\/doi.org\/10.3389\/fmed.2020.00162.","journal-title":"Front Med (Lausanne)"},{"issue":"9151","key":"1130_CR142","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S0140-6736(98)04074-4","volume":"353","author":"AJ Cleare","year":"1999","unstructured":"Cleare AJ, Heap E, Malhi GS, Wessely S, O\u2019Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 1999;353(9151):455\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(98)04074-4.","journal-title":"Lancet."},{"issue":"12","key":"1130_CR143","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.280.12.1061","volume":"280","author":"R McKenzie","year":"1998","unstructured":"McKenzie R, O\u2019Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA. 1998;280(12):1061\u20136. https:\/\/doi.org\/10.1001\/jama.280.12.1061.","journal-title":"JAMA."},{"issue":"4","key":"1130_CR144","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/papr.12613","volume":"18","author":"L Hermans","year":"2018","unstructured":"Hermans L, Nijs J, Calders P, De Clerck L, Moorkens G, Hans G, et al. Influence of morphine and naloxone on pain modulation in rheumatoid arthritis, chronic fatigue syndrome\/fibromyalgia, and controls: a double-blind, randomized, placebo-controlled, cross-over study. Pain Pract. 2018;18(4):418\u201330. https:\/\/doi.org\/10.1111\/papr.12613.","journal-title":"Pain Pract"},{"key":"1130_CR145","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2147\/jpr.s7884","volume":"3","author":"CS Boomershine","year":"2010","unstructured":"Boomershine CS. Pregabalin for the management of fibromyalgia syndrome. J Pain Res. 2010;3:81\u20138. https:\/\/doi.org\/10.2147\/jpr.s7884.","journal-title":"J Pain Res"},{"issue":"8","key":"1130_CR146","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/ars.2014.6181","volume":"22","author":"J Castro-Marrero","year":"2015","unstructured":"Castro-Marrero J, Cordero MD, Segundo MJ, Saez-Francas N, Calvo N, Roman-Malo L, et al. Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal. 2015;22(8):679\u201385. https:\/\/doi.org\/10.1089\/ars.2014.6181.","journal-title":"Antioxid Redox Signal"},{"key":"1130_CR147","doi-asserted-by":"publisher","unstructured":"Tolle M, Freitag H, Antelmann M, Hartwig J, Schuchardt M, van der Giet M, et al. Myalgic encephalomyelitis\/chronic fatigue syndrome: efficacy of repeat immunoadsorption. J Clin Med. 2020;9(8). https:\/\/doi.org\/10.3390\/jcm9082443.","DOI":"10.3390\/jcm9082443"},{"issue":"5","key":"1130_CR148","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bph.13702","volume":"174","author":"J Castro-Marrero","year":"2017","unstructured":"Castro-Marrero J, Saez-Francas N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome\/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174(5):345\u201369. https:\/\/doi.org\/10.1111\/bph.13702.","journal-title":"Br J Pharmacol"},{"key":"1130_CR149","doi-asserted-by":"publisher","first-page":"m4356","DOI":"10.1136\/bmj.m4356","volume":"371","author":"I Torjesen","year":"2020","unstructured":"Torjesen I. NICE backtracks on graded exercise therapy and CBT in draft revision to CFS guidance. BMJ. 2020;371:m4356. https:\/\/doi.org\/10.1136\/bmj.m4356.","journal-title":"BMJ."},{"key":"1130_CR150","doi-asserted-by":"publisher","unstructured":"Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021:1\u201318. https:\/\/doi.org\/10.1080\/23744235.2021.1924397.","DOI":"10.1080\/23744235.2021.1924397"},{"issue":"1","key":"1130_CR151","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.2020.84","volume":"217","author":"K Zhang","year":"2020","unstructured":"Zhang K, Zhou X, Liu H, Hashimoto K. Treatment concerns for psychiatric symptoms in patients with COVID-19 with or without psychiatric disorders. Br J Psychiatry. 2020;217(1):351. https:\/\/doi.org\/10.1192\/bjp.2020.84.","journal-title":"Br J Psychiatry"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-021-01130-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-021-01130-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T16:22:09Z","timestamp":1628180529000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-021-01130-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":151,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s11910-021-01130-1","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"11 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Narges Moghimi, Mario Di Napoli, Jos\u00e9 Biller, James E. Siegler, Rahul Shekhar, Louise D McCullough, Michelle S Harkins, Emily Hong, Danielle A Alaouieh, Gelsomina Mansueto, and Afshin A. Divani each declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"44"}}